Terms: = Liver cancer AND PPFIBP1, L2, 8496, ENSG00000110841, hSGT2, hSgt2p AND Treatment
39 results:
1. Copper(II) Complexes with 1-(Isoquinolin-3-yl)heteroalkyl-2-ones: Synthesis, Structure and Evaluation of Anticancer, Antimicrobial and Antioxidant Potential.
Balewski Ł; Plech T; Korona-Głowniak I; Hering A; Szczesio M; Olczak A; Bednarski PJ; Kokoszka J; Kornicka A
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203181
[TBL] [Abstract] [Full Text] [Related]
2. Reflux conditions induce E-cadherin cleavage and EMT via APE1 redox function in oesophageal adenocarcinoma.
Lu H; Cao LL; Ballout F; Belkhiri A; Peng D; Chen L; Chen Z; Soutto M; Wang TC; Que J; Giordano S; Washington MK; Chen S; McDonald OG; Zaika A; El-Rifai W
Gut; 2023 Dec; 73(1):47-62. PubMed ID: 37734913
[TBL] [Abstract] [Full Text] [Related]
3. Single-cell atlas of the liver myeloid compartment before and after cure of chronic viral hepatitis.
Cui A; Li B; Wallace MS; Gonye ALK; Oetheimer C; Patel H; Tonnerre P; Holmes JA; Lieb D; Yao BS; Ma A; Roberts K; Damasio M; Chen JH; Piou D; Carlton-Smith C; Brown J; Mylvaganam R; Hon Fung JM; Sade-Feldman M; Aneja J; Gustafson J; Epstein ET; Salloum S; Brisac C; Thabet A; Kim AY; Lauer GM; Hacohen N; Chung RT; Alatrakchi N
J Hepatol; 2024 Feb; 80(2):251-267. PubMed ID: 36972796
[TBL] [Abstract] [Full Text] [Related]
4. Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients.
Akbar S; Raza A; Mohsin R; Kanbour A; Qadri S; Parray A; Zar Gul AR; Philip A; Vijayakumar S; Merhi M; Hydrose S; Inchakalody VP; Al-Abdulla R; Abualainin W; Sirriya SA; Al-Bozom I; Uddin S; Khan OM; Mohamed Ibrahim MI; Al Homsi U; Dermime S
Front Immunol; 2022; 13():1097117. PubMed ID: 36741391
[TBL] [Abstract] [Full Text] [Related]
5. Pucotenlimab: First Approval.
Dhillon S
Drugs; 2022 Oct; 82(15):1557-1564. PubMed ID: 36308601
[TBL] [Abstract] [Full Text] [Related]
6. treatment with eFT-508 increases chemosensitivity in breast cancer cells by modulating the tumor microenvironment.
Yang ZY; Jiang CW; Zhang WL; Sun G
J Transl Med; 2022 Jun; 20(1):276. PubMed ID: 35717238
[TBL] [Abstract] [Full Text] [Related]
7. Keratinocyte Carcinomas in Immunocompromised Patients Are Reduced After Administration of the Nonavalent Human Papillomavirus Vaccine.
Nichols A; Nahm W; Rabinovitz H; Ioannides T
J Drugs Dermatol; 2022 May; 21(5):526-528. PubMed ID: 35533038
[TBL] [Abstract] [Full Text] [Related]
8. treatment outcomes of advanced digestive well-differentiated grade 3 NETs.
de Mestier L; Lamarca A; Hernando J; Zandee W; Alonso-Gordoa T; Perrier M; Walenkamp AM; Chakrabarty B; Landolfi S; Van Velthuysen MF; Kats-Ugurlu G; Caminoa A; Ronot M; Manoharan P; Garcia-Alvarez A; Brabander T; García Gómez-Muriel MI; Cadiot G; Couvelard A; Capdevila J; Pavel ME; Cros J
Endocr Relat Cancer; 2021 Jun; 28(8):549-561. PubMed ID: 34061764
[TBL] [Abstract] [Full Text] [Related]
9. 18F-FDG PET/CT imaging for aggressive melanotic schwannoma of the L3 spinal root: A case report.
Shen XZ; Wang W; Luo ZY
Medicine (Baltimore); 2021 Feb; 100(8):e24803. PubMed ID: 33663098
[TBL] [Abstract] [Full Text] [Related]
10. Programmed cell death-1 blockade in kidney carcinoma may induce eosinophilic granulomatosis with polyangiitis: a case report.
Harada M; Naoi H; Yasuda K; Ito Y; Kagoo N; Kubota T; Ichijo K; Mochizuki E; Uehara M; Matsuura S; Tsukui M; Koshimizu N
BMC Pulm Med; 2021 Jan; 21(1):6. PubMed ID: 33407304
[TBL] [Abstract] [Full Text] [Related]
11. Platinum-based chemotherapy in combination with PD-1/PD-L1 inhibitors: preclinical and clinical studies and mechanism of action.
Xue Y; Gao S; Gou J; Yin T; He H; Wang Y; Zhang Y; Tang X; Wu R
Expert Opin Drug Deliv; 2021 Feb; 18(2):187-203. PubMed ID: 32954856
[TBL] [Abstract] [Full Text] [Related]
12. Multicomponent Synthesis, Binding Mode, and Structure-Activity Relationship of Selective Histone Deacetylase 6 (HDAC6) Inhibitors with Bifurcated Capping Groups.
Reßing N; Sönnichsen M; Osko JD; Schöler A; Schliehe-Diecks J; Skerhut A; Borkhardt A; Hauer J; Kassack MU; Christianson DW; Bhatia S; Hansen FK
J Med Chem; 2020 Sep; 63(18):10339-10351. PubMed ID: 32803970
[TBL] [Abstract] [Full Text] [Related]
13. [Molecular mechanism analysis of Erzhi Wan in treatment of aging based on network pharmacology].
Shan S; Wang Q; Wang WL; Wu XY; Yan XJ; Liu HN
Zhongguo Zhong Yao Za Zhi; 2020 Jun; 45(12):2932-2937. PubMed ID: 32627469
[TBL] [Abstract] [Full Text] [Related]
14. Increased both PD-L1 and PD-L2 expressions on monocytes of patients with hepatocellular carcinoma was associated with a poor prognosis.
Yasuoka H; Asai A; Ohama H; Tsuchimoto Y; Fukunishi S; Higuchi K
Sci Rep; 2020 Jun; 10(1):10377. PubMed ID: 32587357
[TBL] [Abstract] [Full Text] [Related]
15. TNF‑α‑mediated epithelial‑to‑mesenchymal transition regulates expression of immune checkpoint molecules in hepatocellular carcinoma.
Shrestha R; Bridle KR; Crawford DHG; Jayachandran A
Mol Med Rep; 2020 Apr; 21(4):1849-1860. PubMed ID: 32319631
[TBL] [Abstract] [Full Text] [Related]
16. The polymorphism rs975484 in the protein arginine methyltransferase 1 gene modulates expression of immune checkpoint genes in hepatocellular carcinoma.
Schonfeld M; Zhao J; Komatz A; Weinman SA; Tikhanovich I
J Biol Chem; 2020 May; 295(20):7126-7137. PubMed ID: 32245889
[TBL] [Abstract] [Full Text] [Related]
17. Mn(II) complex of a vitamin B6 Schiff base as an exclusive apoptosis inducer in human MCF7 and HepG2 cancer cells: Synthesis, characterization, and biological studies.
Tabatabayi ZS; Homayouni-Tabrizi M; Neamati A; Beyramabadi SA
J Cell Biochem; 2020 Mar; 121(3):2677-2689. PubMed ID: 31680295
[TBL] [Abstract] [Full Text] [Related]
18. A Pilot Study of the PD-1 Targeting Agent AMP-224 Used With Low-Dose Cyclophosphamide and Stereotactic Body Radiation Therapy in Patients With Metastatic Colorectal cancer.
Floudas CS; Brar G; Mabry-Hrones D; Duffy AG; Wood B; Levy E; Krishnasamy V; Fioravanti S; Bonilla CM; Walker M; Morelli MP; Kleiner DE; Steinberg SM; Figg WD; Greten TF; Xie C
Clin Colorectal Cancer; 2019 Dec; 18(4):e349-e360. PubMed ID: 31351862
[TBL] [Abstract] [Full Text] [Related]
19. Phase 2 study of pembrolizumab and circulating biomarkers to predict anticancer response in advanced, unresectable hepatocellular carcinoma.
Feun LG; Li YY; Wu C; Wangpaichitr M; Jones PD; Richman SP; Madrazo B; Kwon D; Garcia-Buitrago M; Martin P; Hosein PJ; Savaraj N
Cancer; 2019 Oct; 125(20):3603-3614. PubMed ID: 31251403
[TBL] [Abstract] [Full Text] [Related]
20. Euphorbia factor L2 inhibits TGF-β-induced cell growth and migration of hepatocellular carcinoma through AKT/STAT3.
Fan L; Zhu H; Tao W; Liu L; Shan X; Zhao M; Sun D
Phytomedicine; 2019 Sep; 62():152931. PubMed ID: 31085375
[TBL] [Abstract] [Full Text] [Related]
[Next]
